| Summary of Assets and Liabilities Included as Discontinued Operations and Income (Loss) from Discontinued Operations |
The following table summarizes the carrying amounts of the assets and liabilities included as discontinued operations in the condensed balance sheet at December 31, 2020 (in thousands):
|
|
|
December 31,
|
|
|
|
|
|
2020
|
|
|
|
Assets of discontinued operations
|
|
|
|
|
|
|
Accounts receivable, net
|
|
$
|
214
|
|
|
|
Inventories
|
|
|
1,341
|
|
|
|
Prepaid expenses and other current assets
|
|
|
158
|
|
|
|
Property and equipment, net
|
|
|
684
|
|
|
|
Other long-term assets
|
|
|
78
|
|
|
|
Total assets of discontinued operations
|
|
$
|
2,475
|
|
|
|
|
|
|
|
|
|
|
Liabilities of discontinued operations
|
|
|
|
|
|
|
Accounts payable
|
|
$
|
100
|
|
|
|
Accrued expenses
|
|
|
201
|
|
|
|
Deferred revenue
|
|
|
2,487
|
|
|
|
Total liabilities of discontinued operations
|
|
$
|
2,788
|
|
|
The following table summarizes the major classes of items constituting income (loss) from discontinued operations in the condensed statements of operations for each of the periods presented (in thousands):
|
|
|
Three Months Ended September 30,
|
|
|
Nine Months Ended September 30,
|
|
|
|
|
2021
|
|
|
2020
|
|
|
2021
|
|
|
2020
|
|
|
Net revenues
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Product sales
|
|
$
|
140
|
|
|
$
|
118
|
|
|
$
|
852
|
|
|
$
|
670
|
|
|
Service and other
|
|
|
349
|
|
|
|
729
|
|
|
|
1,748
|
|
|
|
2,259
|
|
|
Total net revenues
|
|
|
489
|
|
|
|
847
|
|
|
|
2,600
|
|
|
|
2,929
|
|
|
Cost of revenues
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Product sales
|
|
|
158
|
|
|
|
347
|
|
|
|
1,201
|
|
|
|
1,127
|
|
|
Service and other
|
|
|
238
|
|
|
|
504
|
|
|
|
1,089
|
|
|
|
1,296
|
|
|
Total cost of revenues
|
|
|
396
|
|
|
|
851
|
|
|
|
2,290
|
|
|
|
2,423
|
|
|
Gross income (loss)
|
|
|
93
|
|
|
|
(4
|
)
|
|
|
310
|
|
|
|
506
|
|
|
Operating expenses
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Selling, general and administrative
|
|
|
330
|
|
|
|
236
|
|
|
|
1,110
|
|
|
|
958
|
|
|
Research and development
|
|
|
134
|
|
|
|
21
|
|
|
|
388
|
|
|
|
47
|
|
|
Total operating expenses
|
|
|
464
|
|
|
|
257
|
|
|
|
1,498
|
|
|
|
1,005
|
|
|
Operating loss
|
|
|
(371
|
)
|
|
|
(261
|
)
|
|
|
(1,188
|
)
|
|
|
(499
|
)
|
|
Interest expense, net
|
|
|
(22
|
)
|
|
|
(3
|
)
|
|
|
(94
|
)
|
|
|
(24
|
)
|
|
Loss from discontinued operations
|
|
|
(393
|
)
|
|
|
(264
|
)
|
|
|
(1,282
|
)
|
|
|
(523
|
)
|
|
Gain on sale of the Dermatology Business
|
|
|
3,473
|
|
|
|
—
|
|
|
|
3,473
|
|
|
|
—
|
|
|
Income (loss) from discontinued operations
|
|
$
|
3,080
|
|
|
$
|
(264
|
)
|
|
$
|
2,191
|
|
|
$
|
(523
|
)
|
|